2015
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer
Oostra D, Lustberg M, Reinbolt R, Pan X, Wesolowski R, Shapiro C. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Molecular And Cellular Endocrinology 2015, 402: 51-56. PMID: 25575458, PMCID: PMC4316829, DOI: 10.1016/j.mce.2014.12.028.Peer-Reviewed Original ResearchConceptsBone mineral densityRapid bone lossFollicle stimulating hormoneBone lossAdjuvant chemotherapyOPG levelsFemoral neckBone resorptionBreast cancerLumbar spineStage I/II breast cancerLS bone mineral densityEarly-stage breast cancerAssociation of osteoprotegerinMonths of amenorrheaMIU/mLNegative pregnancy testNuclear factor kappaChemotherapy initiationPremenopausal womenFSH levelsOsteoclast activationMineral densityStimulating hormonePregnancy test
2013
Association of osteprotegerin, bone turnover, and bone loss after adjuvant chemotherapy in early-stage breast cancer.
Oostra D, Lustberg M, Pan X, Shapiro C. Association of osteprotegerin, bone turnover, and bone loss after adjuvant chemotherapy in early-stage breast cancer. Journal Of Clinical Oncology 2013, 31: 134-134. DOI: 10.1200/jco.2013.31.26_suppl.134.Peer-Reviewed Original ResearchBone mineral densityFollicle stimulating hormoneEarly-stage breast cancerRapid bone lossBreast cancerBone lossAdjuvant chemotherapyFemoral neckBone resorptionLumbar spineStage ILS bone mineral densityCompensatory responseNegative pregnancy testMonth time pointSubsequent bone resorptionOPG increasePremenopausal womenBone healthBone turnoverMIU/Osteoclast activationMineral densityStimulating hormonePregnancy test